NASDAQ: SCYXScynexis Inc Stock Ownership - Who owns Scynexis?
Insider buying vs selling
Have Scynexis Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Gonzalez David Angulo | Chief Executive Officer | 2025-10-17 | 32,500 | $0.76 | $24.70kBuy |
SCYX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when SCYX insiders and whales buy or sell their stock.
SCYX Shareholders
What type of owners hold Scynexis Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Perceptive Advisors LLC | 24.12% | 2,400,000 | $11.62M | Insider |
| Sanofi | 16.86% | 1,677,057 | $8.12M | Insider |
| Gonzalez David Angulo | 13.64% | 1,357,126 | $6.57M | Insider |
| Alta Biopharma Partners II LP | 12.93% | 1,286,311 | $6.23M | Insider |
| Scott Sukenick | 5.77% | 574,539 | $2.78M | Insider |
| Ventech Capital II | 4.16% | 414,211 | $2.00M | Insider |
| Ivor MacLeod | 4.01% | 398,529 | $1.93M | Insider |
| Fcpr Biotechnology Fund | 2.97% | 295,077 | $1.43M | Insider |
| Jeanyves Nothias | 2.97% | 295,077 | $1.43M | Insider |
| Marco Taglietti | 2.73% | 272,068 | $1.32M | Insider |
SCYX vs Pharmaceutical Stocks
Scynexis Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.